Align Technology
ALGN
$171.16
-5.60%
Align Technology Inc. is a leading medical device company specializing in clear aligners under the Invisalign brand and intraoral scanners under the iTero brand, operating in the orthodontic and dental imaging industry. The company holds a dominant market position, controlling over 90% of the clear aligner market, with a vast network of over 230,000 trained dental professionals. Currently, the stock is in the spotlight due to activist investor Elliott Management taking a significant stake, which has sparked optimism about potential value-unlocking initiatives and operational improvements. The market is also closely watching Align's growth trajectory, margin trends, and its ability to expand into new markets and product lines.…
ALGN
Align Technology
$171.16
Related headlines
Investment Opinion: Should I buy ALGN Today?
Based on the analysis, ALGN is rated a Buy, with a thesis that the activist catalyst and undervaluation relative to history provide a favorable risk/reward. The consensus recommendation is 'Buy' with an average target price of $208.60, implying 15.1% upside. The stock's dominant market position and strong gross margins support a premium valuation, but the current P/E of 27.6x is below its historical average, suggesting room for re-rating if growth stabilizes.
Sign up to view all
ALGN 12-Month Price Forecast
The AI assessment leans bullish, driven by the activist catalyst, strong gross margins, and a valuation that is not stretched relative to history. However, the decelerating growth and high PEG ratio warrant caution. The stance would be upgraded to high confidence if revenue growth reaccelerates above 8% and operating margins expand. Conversely, a downgrade to neutral would occur if growth falls below 4% or margins compress below 15%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Align Technology's 12-month outlook, with a consensus price target around $208.60 and implied upside of +21.9% versus the current price.
Average Target
$208.60
0 analysts
Implied Upside
+21.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$170 - $240
Analyst target range
Align Technology has coverage from 15 analysts, with a consensus recommendation of 'Buy' and a mean rating of 2.0 (where 1 is Strong Buy and 5 is Sell). The average price target is $208.60, implying a 15.1% upside from the current price of $181.31. The distribution includes 10 Buy ratings, 4 Hold, and 1 Sell, indicating a bullish sentiment. The target price range spans from $170.00 (low) to $240.00 (high), with the high target suggesting a 32.4% upside, likely assuming successful execution of growth strategies and margin expansion, while the low target implies a 6.2% downside, reflecting concerns about competitive pressures or macroeconomic headwinds. Recent institutional actions show a mix of upgrades and reiterations, with Barclays upgrading from Equal Weight to Overweight in March 2026 and HSBC upgrading from Hold to Buy in February 2026, indicating improving sentiment.
Bulls vs Bears: ALGN Investment Factors
Align Technology presents a mixed picture: its dominant market position, strong gross margins, and activist catalyst provide a solid foundation, while decelerating growth, high valuation, and margin pressures pose risks. The bull case is supported by the potential for operational improvements under Elliott's influence and a reasonable P/E relative to history, but the bear case highlights the elevated PEG and competitive threats. Currently, the evidence slightly favors the bull case, as the activist involvement could unlock value and the stock trades at a discount to its historical average. The key tension is whether Align can reignite growth and expand margins to justify its premium valuation, or if competitive pressures and slowing demand will lead to further de-rating.
Bullish
- Dominant Market Position: Align controls over 90% of the clear aligner market with Invisalign, supported by a network of 230,000 trained dental professionals. This leadership provides pricing power and a strong competitive moat, evidenced by gross margins of 68.3% versus the industry average of 55%.
- Activist Investor Catalyst: Elliott Management's significant stake, reported in March 2026, has sparked optimism for value-unlocking initiatives and operational improvements. The stock jumped on the news, and such activism often leads to cost cuts, capital returns, or strategic refocusing, potentially boosting shareholder value.
- Attractive Valuation vs. History: The trailing P/E of 27.6x is near the lower end of its five-year range (20.7x-97.6x), suggesting the stock is trading at a discount to its own historical valuation. This could indicate a value opportunity if growth stabilizes, especially with a forward P/E of 14.4x implying significant earnings growth.
- Strong Gross Margin Expansion: Gross margin improved to 70.8% in Q1 2026 from 65.7% in Q4 2025, reflecting better cost management and product mix. This expansion supports profitability and provides a buffer against competitive pressures.
Bearish
- Decelerating Revenue Growth: Revenue growth slowed to 6.2% YoY in Q1 2026, down from 7.4% in Q4 2025 and 11.3% in Q3 2025. This deceleration suggests maturing markets and increased competition, which could pressure future earnings and valuation multiples.
- Elevated PEG Ratio: The PEG ratio of 51.8x is extremely high, indicating that the stock is overvalued relative to its growth rate. This suggests the market is pricing in aggressive future growth that may not materialize, posing a risk of multiple compression.
- High Beta and Volatility: With a beta of 1.65, ALGN is 65% more volatile than the market, amplifying downside risk in market downturns. The stock has experienced a max drawdown of -39.7% over the past year, highlighting significant price swings.
- Operating Margin Pressure: Operating margin compressed to 16.6% in Q1 2026 from 15.2% in Q4 2025, despite gross margin expansion. This indicates rising operating expenses, including R&D and SGA, which could limit earnings growth if not managed.
ALGN Technical Analysis
Align Technology's stock is in a strong uptrend over the past year, with a 1-year price change of +26.9%, significantly outperforming the S&P 500's +20.4% gain. The current price of $181.31 sits at 90.5% of its 52-week range (between $122.00 low and $200.44 high), indicating the stock is trading near its highs, which reflects robust momentum but also potential overextension. The stock's beta of 1.65 suggests it is 65% more volatile than the market, amplifying both upside and downside moves.
Beta
1.65
1.65x market volatility
Max Drawdown
-39.7%
Largest decline past year
52-Week Range
$122-$200
Price range past year
Annual Return
+20.2%
Cumulative gain past year
| Period | ALGN Return | S&P 500 |
|---|---|---|
| 1m | -3.2% | +4.0% |
| 3m | +10.3% | +5.3% |
| 6m | -10.3% | +12.6% |
| 1y | +20.2% | +20.1% |
| ytd | +9.7% | +13.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ALGN Fundamental Analysis
Align Technology's revenue growth has been steady, with the most recent quarter (Q1 2026) reporting revenue of $1.04 billion, a 6.2% year-over-year increase. This growth is driven by both the Clear Aligner segment ($794.3 million) and Scanners and Services ($200.9 million), with the aligner business remaining the core growth engine. However, growth has decelerated from prior quarters, as Q4 2025 revenue was $1.05 billion, and Q3 2025 was $995.7 million, indicating a sequential slowdown. The company's net income for Q1 2026 was $112.8 million, with a net margin of 10.8%, which is lower than the 12.9% margin in Q4 2025, reflecting increased operating expenses and investments. Gross margin remains strong at 70.8% in Q1 2026, up from 65.7% in Q4 2025, but operating margin compressed to 16.6% from 15.2% in the prior quarter, indicating cost pressures.
Quarterly Revenue
$1.0B
2026-03
Revenue YoY Growth
+6.2%
YoY Comparison
Gross Margin
70.8%
Latest Quarter
Free Cash Flow
$686093000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ALGN Overvalued?
Given Align's positive net income, the trailing P/E ratio of 27.6x is the primary valuation metric, while the forward P/E of 14.4x suggests the market expects significant earnings growth, implying a PEG ratio of 51.8x, which is elevated. Compared to the industry average P/E of 22x, Align trades at a 25% premium, reflecting its market leadership and growth prospects, but the premium may be justified by its superior gross margins (68.3% vs. industry average of 55%) and strong ROE of 10.1%. Historically, Align's P/E has ranged from 20.7x to 97.6x over the past five years, and the current 27.6x is near the lower end of that range, suggesting the stock is trading at a discount to its own historical valuation, which could indicate a value opportunity or reflect lower growth expectations.
PE
27.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 21x~73x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks include a moderate debt-to-equity ratio of 0.03, indicating low leverage, but the company's reliance on continued growth to justify its valuation is a concern. The PEG ratio of 51.8x implies the market expects exceptional earnings growth, and any shortfall could lead to multiple compression. Additionally, operating margin pressure, with Q1 2026 operating margin at 16.6% versus 15.2% in Q4 2025, suggests rising costs that could erode profitability if not controlled. Free cash flow remains positive at $686 million TTM, but the company's net margin of 10.8% is below the 12.9% in Q4 2025, indicating some earnings volatility.